{"id":854,"date":"2020-03-05T08:59:29","date_gmt":"2020-03-05T08:59:29","guid":{"rendered":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/resultats-de-la-recherche-sur-ladn-tumoral-circulant\/"},"modified":"2026-03-31T15:25:30","modified_gmt":"2026-03-31T15:25:30","slug":"research-results-on-circulating-tumour-dna-2","status":"publish","type":"post","link":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/research-results-on-circulating-tumour-dna-2\/","title":{"rendered":"R\u00e9sultats de la recherche sur l&rsquo;ADN tumoral circulant"},"content":{"rendered":"<p>\u00a0<\/p>\n<p><em>Ce projet de recherche a \u00e9t\u00e9 financ\u00e9 par Cancer du rein Canada, l\u2019Association des urologues du Canada et le R\u00e9seau de recherche sur le cancer du rein du Canada<\/em><\/p>\n<p><strong>ADN tumoral circulant dans le plasma et h\u00e9matopo\u00ef\u00e8se clonale chez les patients atteints d\u2019un carcinome \u00e0 cellules r\u00e9nales m\u00e9tastatique<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Les cellules du corps suivent un cycle constant de croissance, de division et de mort. Quand des cellules matures meurent, elles lib\u00e8rent dans le sang leur ADN, qui est alors d\u00e9compos\u00e9 par des enzymes sp\u00e9cialis\u00e9s. Chez les patients canc\u00e9reux, les tumeurs participent \u00e9galement \u00e0 ce processus et contribuent \u00e0 la production \u00ab\u00a0d\u2019ADN tumoral circulant\u00a0\u00bb. Ces fragments d\u2019ADN d\u2019origine tumorale peuvent \u00eatre isol\u00e9s \u00e0 partir d\u2019une analyse sanguine standard et utilis\u00e9s dans le cadre de tests g\u00e9n\u00e9tiques non effractifs.<\/p>\n<p>Dans un article paru r\u00e9cemment dans la revue m\u00e9dicale <em>Clinical Genitourinary Cancer<\/em>, Dre Lucia Nappi et Jack Bacon, de l\u2019Universit\u00e9 de la Colombie-Britannique, ont d\u00e9montr\u00e9 que les patients atteints d\u2019un cancer du rein et pr\u00e9sentant un taux sup\u00e9rieur d\u2019ADN tumoral circulant sont expos\u00e9s \u00e0 un risque consid\u00e9rablement accru d\u2019\u00e9chec th\u00e9rapeutique et de d\u00e9c\u00e8s par rapport \u00e0 ceux chez qui ce taux est faible ou ind\u00e9tectable.<\/p>\n<p>Cette information, de concert avec les crit\u00e8res de pronostic existants dans le domaine du cancer du rein, pourrait un jour servir \u00e0 orienter les d\u00e9cisions th\u00e9rapeutiques des professionnels m\u00e9dicaux.<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 Ce projet de recherche a \u00e9t\u00e9 financ\u00e9 par Cancer du rein Canada, l\u2019Association des urologues du Canada et le R\u00e9seau de recherche sur le cancer du rein du Canada ADN tumoral circulant dans le plasma et h\u00e9matopo\u00ef\u00e8se clonale chez les patients atteints d\u2019un carcinome \u00e0 cellules r\u00e9nales m\u00e9tastatique \u00a0 Les cellules du corps suivent [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":849,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"year-of-the-new":[32],"class_list":["post-854","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee","year-of-the-new-32"],"_links":{"self":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/comments?post=854"}],"version-history":[{"count":1,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/854\/revisions"}],"predecessor-version":[{"id":855,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/854\/revisions\/855"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/media\/849"}],"wp:attachment":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/media?parent=854"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/categories?post=854"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/tags?post=854"},{"taxonomy":"year-of-the-new","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/year-of-the-new?post=854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}